199 results
8-K
EX-99.1
REGN
Regeneron Pharmaceuticals, Inc.
1 Aug 24
Regeneron Reports Second Quarter 2024 Financial and Operating Results
7:06am
relations website and social media outlets to publish important information about the Company, including information that may be deemed material
8-K
EX-99.1
REGN
Regeneron Pharmaceuticals, Inc.
2 May 24
Regeneron Reports First Quarter 2024 Financial and Operating Results
7:06am
website and social media outlets to publish important information about the Company, including information that may be deemed material to investors
8-K
EX-99.1
absyao u50d8
2 Feb 24
Regeneron Reports Fourth Quarter and Full Year 2023 Financial and Operating Results
7:16am
8-K
EX-99.1
f7isx59r3hqj9apdli7m
2 Nov 23
Regeneron Reports Third Quarter 2023 Financial and Operating Results
7:10am
SC TO-T/A
i11k gw73t
25 Sep 23
Third party tender offer statement (amended)
8:48am
SC TO-T/A
2fk fp5q9qqo3bczl0
12 Sep 23
Third party tender offer statement (amended)
4:38pm
SC TO-T/A
gr4esm
8 Sep 23
Third party tender offer statement (amended)
4:05pm
SC TO-T
rianuuhitmpn0l4p f1c
25 Aug 23
Third party tender offer statement
7:46am
SC TO-T
EX-99
w919wjta12
25 Aug 23
Third party tender offer statement
7:46am
SC TO-T
EX-99
oe7blrh1elz62 x9
25 Aug 23
Third party tender offer statement
7:46am
SC TO-C
1wp4kb6
9 Aug 23
Information about tender offer
4:15pm
8-K
EX-99.1
dz72fimcw 3hb6y3t
3 Aug 23
Regeneron Reports Second Quarter 2023 Financial and Operating Results
6:48am